Not available
Quote | Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)
Last: | $20.03 |
---|---|
Change Percent: | 1.26% |
Open: | $19.76 |
Close: | $19.78 |
High: | $20.19 |
Low: | $19.5 |
Volume: | 352,291 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)
2024-06-28 12:08:19 ET Summary Rocket Pharmaceuticals stock dropped pre-market after management reported receiving a Complete Response Letter from the FDA in relation to Kresladi, indicated for severe leukocyte adhesion deficiency-I. The rejection was based on Chemistry Manufactur...
2024-06-28 08:21:35 ET More on Rocket Pharmaceuticals Rocket Pharmaceuticals: Cautiously Optimistic (Rating Upgrade) Rocket Pharmaceuticals: Multiple Regulatory Submissions Make It A Must Watch Cantor picks 14 undervalued biotech stocks worth a second look Ro...
Message Board Posts | Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RCKT News Article - Rocket Pharmaceuticals to Participate in the 43rd Annual Cowen Hea | whytestocks | investorshangout | 03/01/2023 9:05:48 PM |
whytestocks: $RCKT News Article - Rocket Pharmaceuticals Presents Positive Clinical Data from Fancon | whytestocks | investorshangout | 12/12/2022 4:10:48 PM |
whytestocks: $RCKT News Article - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, | whytestocks | investorshangout | 10/28/2022 7:50:57 PM |
whytestocks: $RCKT News Article - Rocket Pharmaceuticals Announces Presentations Highlighting Lentiv | whytestocks | investorshangout | 10/12/2022 3:45:49 PM |
whytestocks: $RCKT News Article - Rocket Pharmaceuticals to Present at the 2022 Cell & Gene Meeting | whytestocks | investorshangout | 10/10/2022 12:25:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Rocket Pharmaceuticals Inc. Company Name:
RCKT Stock Symbol:
NASDAQ Market:
Rocket Pharmaceuticals Inc. Website:
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet needs, today announced a regulatory update for KRESLADI™ (marnetegragene autotemcel; marne-cel), a le...
2024-06-02 14:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the European Commission (EC), based on a positive opinion issued by the Committ...